Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles


Amlodipine in the Prevention and Treatment of Cardiovascular Disease

Alejandro de la Sierra,

Citation: European Cardiovascular Disease 2007;3(2):66–8

Aliskiren - Clinical Benefits in the Management of Hypertension

Roland E Schmieder,

Citation: European Cardiovascular Disease 2007;3(2):61–4

Advances in the Treatment of Pulmonary Arterial Hypertension

Robert Voswinckel, Ralph T Schermuly, Norbert Weissmann,

Citation: European Cardiovascular Disease 2007;3(1):105–8

Endothelin and Pulmonary Arterial Hypertension

John R Teerlink,

Citation: US Cardiology 2005;2(1):1-5